You are here

Company Monitoring Page for Amgen

job ratings (see below graph) for Amgen

latest headlines for company on cafepharma

Don't Underestimate Amgen: Part 1

Seeking Alpha

Fri, 01/10/14 - 08:37 am

Tags:

Amgen, Celgene, Gilead Sciences, Biogen Idec

Amgen Vs. Merck, Lilly In Osteoporosis Competition

Seeking Alpha

Thu, 01/9/14 - 08:33 am

Tags:

Amgen, Merck, Eli Lilly, osteoporosis, romosozumab, UCB Pharmaceuticals, Prolia, Forteo, Fosamax

Semantics 101: Goldman’s Biotech Downgrade and the New Biotech Consensus

Barron's

Mon, 01/6/14 - 11:44 am

Tags:

biotech, Amgen, Regeneron

The Surprising Way Big Pharma Is Researching New Drugs

Motley Fool

Mon, 01/6/14 - 09:58 am

Tags:

22 Biotech Stock Predictions for 2014

TheStreet.com

Mon, 01/6/14 - 09:47 am

Amgen, UCB Drug Increases Bone Density in Phase 2 Trial

Drug Discovery and Development

Fri, 01/3/14 - 12:50 pm

Tags:

UCB, Amgen, bone density, romosozumab

Grading Pharma In 2013: 16 Drug Companies Ranked

Forbes

Tue, 12/31/13 - 10:17 am

Tags:

Bristol-Myers Squibb, Celgene, Gilead Sciences, Biogen Idec, AbbVie, Roche, JNJ, GSK, Amgen, Novo Nordisk, Pfizer, Novartis, Merck, Sanofi, AstraZeneca, Eli Lilly

Acceleron, Celgene Vs. Amgen In The Anemia Drug Race

Seeking Alpha

Mon, 12/30/13 - 11:15 am

Tags:

Amgen, Acceleron, Celgene, anemia, sotatercept, ACE-536

Biogen's Biosimilars Vs. Amgen, Johnson & Johnson

Seeking Alpha

Mon, 12/23/13 - 10:01 am

Tags:

Amgen, Biogen Idec, biosimilars, JNJ, Samsung Bioepis, Celltrion, Hospira, Remsima, Inflectra

Biotech Stocks: A Year in Review

Yahoo/TheStreet.com

Fri, 12/20/13 - 08:34 am

Tags:

Amgen, Teva, Forest Labs, AstraZeneca, Medivation, JNJ

Amgen cholesterol drug succeeds in late-stage trial

Yahoo/Reuters

Thu, 12/19/13 - 11:13 am

Tags:

Amgen, cholesterol, evolocumab, PCSK9 inhibitors

The Race To Treat Stage III Melanoma Just Got A Lot More Interesting

Seeking Alpha

Wed, 12/18/13 - 08:18 am

Tags:

melanoma, Amgen, Inovio, OncoSec Medical, TVEC

Keep an Eye on Biogen, Johnson & Johnson, and Merck Today

Motley Fool

Tue, 12/17/13 - 10:42 am

Tags:

Biogen Idec, JNJ, Merck, Bravecto, animal health, Samsung, Hospira, Amgen, AbbVie, anti-TNF

Amgen announces MENDEL-2 Phase 3 trial met co-primary endpoints

Yahoo/Fly on the Wall

Tue, 12/17/13 - 09:37 am

Tags:

Amgen, evolocumab, cholesterol

Ziopharm: Finally A Winner In The War On Cancer?

Seeking Alpha

Mon, 12/16/13 - 08:06 am

Tags:

Ziopharm, cancer, AbbVie, Amgen, Celgene, Celldex Therapeutics, Gilead Sciences, Immunogen, JNJ, ImmunoCellular Therapeutics, Pharmacyclics, Intrexon, Seattle Genetics

Amgen Announces 2014 First Quarter Dividend

Yahoo/PR NewsWire

Sat, 12/14/13 - 11:42 am

Tags:

Better Earnings: Celgene, Biogen, Or Amgen?

Motley Fool

Fri, 12/6/13 - 08:58 am

Tags:

Celgene, Biogen Idec, earnings, Amgen

You Call That Efficacy? FDA Warns Amgen For Aranesp Promotion

Pharmalot

Wed, 11/27/13 - 08:51 am

Tags:

FDA, Amgen, Aranesp

Slouching Toward Phase 3: Progress Report On New Cholesterol Drugs At The AHA

Forbes

Mon, 11/25/13 - 09:12 am

Tags:

cholesterol, PCSK9 inhibitors, evolocumab, Amgen

3 New Cholesterol Treatments Worth Watching

Motley Fool

Sun, 11/24/13 - 12:46 pm

Tags:

Sanofi, Regeneron, Amgen, alirocumab, AMG 145, RN-316, Pfizer

Pages

last 30 twitter posts